透
01332
透雲生物
0.164
+0.011+7.19%Closed15:57 04/17 HKT
OPEN/PREV CLOSE0.170/0.169
TODAY RANGE0.170-0.196
VOL6.77M
MARKET CAP499.46M
52 WEEK RANGE0.067-0.750
AVG VOL (3M)18.70M
% TURNOVER0.24%
TURNOVER1.28M
P/E (TTM)18.542
% RANGE15.38%
EPS(TTM)0.010
P/E(FORWARD)--
P/B-9.780
BVPS-0.018
DIVIDEND--
P/S6.953
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP499.46M
SHARES OUTSTANDING2.81B
NEXT EARNINGS--
FREE FLOAT2.81B
LOT SIZE10000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·03/27 14:24
TOUYUN BIOTECH GROUP FY REVENUE HKD 67 MILLION
Simply Wall St·01/26 22:41
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 54%
Simply Wall St·12/12/2025 22:01
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 40%
Reuters·12/11/2025 12:03
Touyun Biotech Group Fails to Repay RMB150 Million Loan and Seeks Extension
Simply Wall St·12/08/2025 22:01
Recent 14% pullback isn't enough to hurt long-term Touyun Biotech Group (HKG:1332) shareholders, they're still up 46% over 1 year
Reuters·11/03/2025 12:02
Touyun Biotech Clarifies Unusual Share Movements and Confirms Normal Operations
Simply Wall St·10/13/2025 00:15
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 31%
Simply Wall St·09/18/2025 22:15
Touyun Biotech Group First Half 2025 Earnings: EPS: HK$0.007 (vs HK$0.013 loss in 1H 2024)
Simply Wall St·08/28/2025 22:22
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 25%
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.